WƌĞƐƐ WĂĐŬ - Europe Unlimited

WƌĞƐƐWĂĐŬ
WƌĞƐƐWĂĐŬ
Overwhelming Success for MedTech Summit in Switzerland
Geneva, November 26th 2008 – The European Tech Tour MedTech Summit was held in
Montreux and Lausanne, Switzerland on November 19 and 20, 2008. This first and very
successful MedTech summit aimed at bringing together Europe’s most promising MedTech
companies, leading venture capitalists and senior industry professionals.
Brian Hashemi, President of the MedTech Summit, Beat Mertz, Vice President, and the 22
senior professionals serving on the International Selection Committee selected 24
companies from an initial list of 240 companies for presentation at the Summit. The finalists
were: BioControl Medical, Glusense, biospace med, CeQur, Elana, Endosense,
EyeSense, Fertility Focus, Forth Photonics, Intelligent Medical Implants, Kuros
Biosurgery,
Michelson
Leman
Cardiovascular,
Diagnostics,
Novalung,
Lifebridge
NovaShunt,
Medizintechnik,
Occlutech,
MaestroHeart,
Optinose,
Pantec
Biosolutions, Skyline Diagnostics, Slender Medical, Symetis, Vexim. “These companies
represent the very best technologies from across the sector including Cardiology,
Orthopaedics, Medical Intervention, Artificial Organ/Assist, Ophthalmology, Drug Delivery,
Diagnostics, and Imaging.” Each company had twenty minutes to present their business
plans to an international delegation of more than 100 influential investors, technology
industry leaders and service providers who had signed up for the event with a view to
investing or supporting these young companies achieve their globalization plans.
The MedTech Summit aimed to assemble the ecosystem of European Medtech by bringing
together the CEOs of the most promising MedTech companies, the investment professionals
that finance this sector, and senior industry professionals from the global firms that drive the
industry. Among the global firms represented at the Summit were Advanced Medical Optics
(AMO), Boston Scientific, Edwards Lifesciences, Synthes, Zimmer, and of course Medtronic,
the sponsoring partner for the event. The Summit also attracted representatives from over
30 investment firms from the United States, Europe, and Israel and generated a lot of
positive interest in the media.
Scott Parazynski, a medical doctor, MedTech inventor, and NASA Astronaut held the
keynote address at the opening gala dinner that was staged at Château de Chillon in
Montreux and demonstrated that medical technologies are vital in extreme environments
such as space travel and exploration.
Summit to showcase 24 outstanding European MedTech companies
Geneva, November 11th, 2008 – The European Tech Tour MedTech Summit will open in
Montreux, Switzerland on November 19th, 2008. The Summit will bring together Europe’s
most innovative Medical Technology companies with leading venture capitalists and leading
industry professionals. The Summit is a unique assembly of the ecosystem for MedTech
in Europe, a market that will attract over 5 billion USD of private investment globally.
The Summit will showcase 24 outstanding European and Israeli MedTech companies chosen
competitively by a Selection Committee of 20 leading investment professionals and corporate
executives; the committee reviewed and evaluated a large number of applications before
nominating the finalists. Dr. Brian Hashemi, President of the 2008 European MedTech
Summit says “By bringing together the ecosystem of MedTech we expect to enable new
ventures and partnerships. I have been impressed with the quality of the selected companies
half of which are in the early stage of development and half in the expansion stage. These
companies represent the very best technologies from across the sector including Cardiology,
Orthopaedics, Medical Intervention, Artificial Organ/Assist, Ophthalmology, Drug Delivery,
Diagnostics, and Imaging.”
The Summit will explore the future of the MedTech innovation and Scott Parazynski, a
medical doctor, MedTech inventor, and NASA Astronaut, who will present the keynote
speech at the November 19th Gala dinner at Château de Chillon, says “The global healthcare
community will greatly benefit from the many exciting technologies that will be making a
significant impact on patients’ lives. The most advanced laboratories for MedTech are
extreme environments such as space travel and exploration. I am delighted to participate in
the 2008 European MedTech Summit and meet Europe’s most promising MedTech
companies.”
The CEOs of the 24 selected companies come from Switzerland, Germany, Israel,
France, United Kingdom, The Netherlands, Norway, and Liechtenstein. They will each
have twenty minutes to present their business plan to an international delegation of more
than 100 influential investors, MedTech industry leaders, and other leading industry
professionals who have signed up for the event with a view to investing or aiding these
companies achieve their globalisation plans. These delegates come from across Europe, the
United States, Israel, China, and Japan and will participate in discussion on important issues
facing the industry such as refinancing, growth, and exits in turbulent times, trends in
medicine and technology, healthcare systems, individualized medicine, consumer directed
care, and reimbursement of medical technologies.
Summit participants will continue with the program at Ecole Polytechnique Fédérale de
Lausanne on November 20th where they will receive a welcome presentation by Professor
Patrick Aebischer and other EPFL faculty.
About European Tech Tour – www.techtour.com
The European Tech Tour Association (ETT) is a non-profit organisation founded by Sven
Lingjaerde in Switzerland in 1998 and has successfully organised 30 Tech Tours across
Europe, Israel, Russia, and India, since its inception ten years ago. ETT is an independent
organisation composed of key contributors to the high-technology industry and responds to
the growing interest to visit emerging technology companies in various European regions.
###
If you would like an invitation to the event, please contact Weber Shandwick in
Geneva. The agency will be happy to arrange interviews for your media.
Weber Shandwick Switzerland
Mrs. Alexia Fanni
Tel: +41 (0)22 879 85 07
[email protected]
On the second day of the Summit the delegates continued their deliberations at the Ecole
Polytechnique Fédérale de Lausanne (EPFL) where President Patrick Aebischer
presented a welcome speech highlighting important innovations in technology and life
sciences at this world-renowned technical institution. Among the attendees were CEOs of
medical technology companies that are spin off of EPFL.
About European Tech Tour – www.techtour.com
The European Tech Tour Association (ETT) is a non-profit organisation founded by Sven
Lingjaerde in Switzerland in 1998 and has successfully organised 30 Tech Tours across
Europe, Israel, Russia, and India, since its inception ten years ago. ETT is an independent
organisation composed of key contributors to the high-technology industry and responds to
the growing interest to visit emerging technology companies in various European regions.
###
For more information please contact:
Weber Shandwick Switzerland
Mrs. Alexia Fanni
Tel: +41 (0)22 879 85 07
[email protected]
Industry leaders to sponsor the European Tech Tour MedTech Summit 2008
Geneva, October 10, 2008 – The European Tech Tour MedTech Summit 2008, today
announced a range of top-line, industry-leading sponsors for the event which will bring
together Europe’s most innovative Medical Technology companies with senior industry
professionals and leading investors. The Summit will be held on November19-20th in
Montreux and Lausanne, Switzerland and will focus on the medical technology sector – one
that has seen exceptional growth in investment, and a range of innovative solutions that will
significantly impact global healthcare in the coming decade. Total VC funding in the US alone
reached US$4.1 billion in 2007, a 37% increase over the previous record-setting year of
2006.
The Summit, sponsored by Medtronic, Swiss MedTech, Swiss Exchange, EndeavourVision,
Neomed, Highland Capital Partners, Earlybird, J&J Development Corp, Audemars Piguet,
Ecole Polythechnique Fédérale de Lausanne, BioAlps, and Swiss Canton de Vaud will
highlight companies in all stages of development including seed, start-up, expansion and
pre-IPO that are active in segments across the Medical Technology Market.
Dr. Oern Stuge, President International, Medtronic states that “Many of the important
innovations in medical technology have come from Europe. These innovations have changed
the way we practice medicine and made a significant impact on people’s lives. If history is a
good predictor for the future, major innovations within medical technology will come out of
Europe".
Mr. Sven Lingjaerde, Partner at EndeavourVision says “The 2008 MedTech Summit is a
unique opportunity to meet some of the most promising CEOs of European MedTech startups and to evaluate new opportunities with significant impact potential on global healthcare.”
Dr. Claudio Nessi, Partner at NeoMed says “I am impressed with the quality of the
MedTech companies that have applied to the Selection Committee of the European
MedTech Summit and look forward to the presentations of Europe and Israel’s most
promising CEOs”.
Mr. Thom Rasche, Partner at Earlybird Venture Capital says “Europe has excellent
science and engineering and ideal for building new innovative MedTech companies.
The 2008 European MedTech Summit is the ideal forum to stimulate collaboration between
Finance, Corporations, and Entrepreneurs.”
Switzerland has traditionally played a leading role in innovation of medical technology and is
a natural host for the European MedTech Summit. Mr. Raphaël Conz of Canton de Vaud,
Switzerland says “Hosting the European MedTech Summit is a tremendous opportunity for
the Canton of Vaud, as well as for companies and institutions in the region. Indeed this
Summit helps to strengthen the position of the canton in life sciences, an area of economic
development priority. In addition, it will offer regional start-ups the possibility to establish
contacts with many investors worldwide.”
Dr. Brian Hashemi, President, European MedTech Summit says “It has been a great
pleasure working with our sponsoring partners and the response from the global MedTech
community has been tremendous. Over 30% of the companies that have applied to the
Selection Committee for presentation are in late stage expansion with 50% representing the
most innovative Startups from across the market including Cardiovascular, Orthopaedics,
Neurology, Ophthalmology, Drug Delivery, and Imaging”.
About European Tech Tour - www.techtour.com
The European Tech Tour Association (ETT) is a non-profit organization founded by Sven
Lingjaerde in Switzerland in 1998 and has successfully organised 30 Tech Tours across
Europe, Israel, Russia and India, since its inception ten years ago. ETT is an independent
organisation composed of key contributors to the high-technology industry and responds to
the growing interest to visit emerging technology companies in various European regions.
###
For more information, please contact:
Weber Shandwick Switzerland
Mrs. Alexia Fanni
Tel: +41 (0)22 879 85 07
[email protected]
Les grands noms de l'industrie soutiennent le European Tech Tour MedTech Summit 2008
Genève, le 10 octobre 2008 – Le MedTech Summit 2008 du European Tech Tour a révélé
aujourd'hui l'identité de ses sponsors, tous leaders dans leurs domaines respectifs, qui
soutiendront cet événement. Cette rencontre au sommet représente une occasion unique pour
les entreprises européennes les plus innovantes en matière de technologie médicale de
rencontrer des experts du secteur industriel ainsi que des investisseurs de haut niveau. Le
MedTech Summit se tiendra le 19 et 20 novembre à Montreux et à Lausanne, en Suisse, et
focalisera son attention sur les technologies médicales, un secteur d'activités qui enregistre
actuellement une croissance exceptionnelle au niveau des investissements. Diverses solutions
innovantes pouvant avoir un impact significatif sur les soins de santé dans le monde dans le
courant des dix prochaines années y seront étudiées. Aux États-Unis, le financement de ce
secteur, principalement à l'aide de capital-risque, a atteint un total de 3.7 milliards de dollars US
en 2007, ce qui représente une augmentation de 37% par rapport à l'année précédente, qui était
déjà une année record.
Le Summit, qui est organisé avec le soutien de Medtronic, Swiss MedTech, Swiss Exchange,
EndeavourVision, Neomed, Highland Capital Partners, Earlybird, J&J Development Corp,
Audemars Piguet, l'Ecole Polythechnique Fédérale de Lausanne, BioAlps et le Canton de Vaud,
présentera des entreprises à tous les niveaux de développement (seed, start-up, expansion et
pré-IPO) et actives dans les différents segments du marché des technologies médicales.
Président international du groupe Medronic le Dr. Oern Stuge explique que «Beaucoup
d'innovations importantes dans le domaine de la technologie médicale ont leur source en
Europe. Ces innovations ont, d’une part, révolutionné la pratique de la médecine et, d’autre part,
eu un impact significatif sur la vie des gens. Et si l'histoire est un bon indicateur pour ce qui va
se passer à l'avenir, l'Europe sera à l'origine de bon nombre d'innovations majeures issues du
secteur de la technologie médicale.»
Selon M. Sven Lingjaerde, associé chez EndeavourVision, «L’édition 2008 du MedTech
Summit représente une opportunité unique de rencontrer les PDG des start-ups européennes
les plus prometteuses dans le secteur de la technologie médicale et sert aussi à évaluer le
potentiel des nouvelles opportunités qui se profilent en matière de soins de santé.»
Le Dr. Claudio Nessi, associé chez NeoMed, se dit «Impressionné par le haut niveau de
qualité des sociétés spécialisées en technologie médicale ayant déposé leur candidature auprès
du comité de sélection de l’European MedTech Summit et attend avec impatience les
présentations des PDG les plus prometteurs d’Europe et d’Israël.»
«L’Europe dispose d’excellente science et technologie et, de ce fait, est un terrain propice à la
création de sociétés novatrices dans le domaine de la technologie médicale. L’édition 2008 du
European MedTech Summit est le forum idéal pour stimuler la collaboration entre investisseurs,
sociétés et entrepreneurs», ajoute M. Thom Rasche, associé chez Earlybird Venture Capital.
La Suisse est réputée pour être un leader dans les secteurs de la technologie et de l’innovation
médicale; de ce fait, elle est le pays d’accueil par excellence pour l’European MedTech Summit.
M. Rafael Conz, Canton de Vaud (Suisse), ajoute que «Accueillir l’European MedTech Summit
représente une opportunité précieuse pour le Canton de Vaud, tout comme pour les entreprises
et les institutions de la région. En effet, cette rencontre au sommet renforce encore le
positionnement du canton dans le domaine des sciences de la vie. De plus, il offre aux start-ups
locales la possibilité de nouer des contacts avec un grand nombre d’investisseurs venus du
monde entier.»
Le Dr. Brian Hashemi, Président de l’European MedTech Summit, conclut: «Nous avons eu
beaucoup de plaisir à collaborer avec nos sponsors et la communauté MedTech a réagi avec un
bel enthousiasme. En effet, plus de 30% des sociétés qui ont déposé leur candidature auprès du
comité de sélection se situent à un niveau de développement avancé; une sur deux est une
start-up des plus prometteuses sur le marché des technologies médicales représentant des
segments de marché les plus variés, comme la médecine cardio-vasculaire, l’orthopédie, la
neurologie, l’ophtalmologie, l’administration de médicaments et l’imagerie médicale.»
European Tech Tour – www.techtour.com
European Tech Tour Association (ETT) est une organisation sans but lucratif fondée par Sven
Lingjaerde à Genève en 1998. Depuis sa création il y a dix ans, l'association a d'ores et déjà
mis sur pied une trentaine de circuits techniques, les "Tech Tours" qui se sont déroulés en
Europe, en Israël, en Russie et en Inde. L’ETT est une organisation indépendante rassemblant
les principaux représentants de l’industrie high-tech et répond à un intérêt croissant de rendre
visite à des entreprises de technologie dans les différentes régions d'Europe.
###
Pour plus informations, veuillez prendre contact avec:
Weber Shandwick Switzerland
Mme. Alexia Fanni
Tél.: +41 (0)22 879 85 07
[email protected]
The European Tech Tour Association announces its first MedTech Summit
Geneva, September 9th, 2008 – The European Tech Tour Association announced today the
launch of the ETT MedTech Summit 2008, held on November19-20th in Montreux and
Lausanne, Switzerland. The MedTech summit will be focused on the medical technology
sector and will bring together Europe’s most innovative Medical Technology companies with
leading venture capitalists and senior industry professionals. This is the first competition of its
kind in the MedTech sector with a Selection Committee of twenty senior professionals
evaluating over 200 companies and selecting the 25 most promising MedTech companies for
invitation to the Summit.
Due to the baby boom and the world’s aging population, global healthcare is in dire need of
innovation in medical technology to improve quality and increase efficiency of healthcare
systems. The principal aim of the Summit is to evaluate MedTech companies in all stages of
development including seed, start-up, expansion and pre-IPO, and to highlight the most
promising companies from across the Medtech sector including cardiovascular, neurology,
ophthalmology, drug delivery, imaging and robotics, biomaterials, dental, minimal invasive
surgery, and orthopaedics.
Brian Hashemi, President of the MedTech Summit 2008, said: “MedTech is one of the
fastest growing investment sectors due to the increasing demand on healthcare systems
around the world. The goal of the 2008 European Tech Tour’s MedTech Summit is to
assemble the ecosystem of MedTech to debate important issues relating to this growing
sector, and to introduce the most promising European MedTech companies to investment
professionals and corporate executives from Europe, the United States, and Asia“
Benefits for finalists
The 25 finalists will represent the very best medical technology companies and at no cost to
the company receive a twenty minute slot to present their business plans to senior partners,
vice presidents and CEOs representing the global venture capital and technology industry.
In addition, they will benefit from:
•
Networking with 300 delegates consisting of professionals from the
MedTech industry and venture capital community
•
Local and international media exposure
•
Potential opportunities to secure funding and partnership with global players
About European Tech Tour
The European Tech Tour Association (ETT) is a non-profit organisation founded by Sven
Lingjaerde in Switzerland in 1998 and has successfully organised 30 Tech Tours across
Europe, Israel, Russia, and India, since its inception ten years ago. ETT is an independent
organisation composed of key contributors to the high-technology industry and responds to
the growing interest to visit emerging technology companies in various European regions.
The European Tech Tour Association recognises that the European continued prosperity lies
in its ability to transform today's innovative projects into tomorrow's global technology
leaders. Focused on the global expansion of emerging companies with a high index of
growth, the association’s main objective is to provide independent leading platforms
designed to identify and support the emerging companies with the necessary potential to
impact in the technological global scenario.
###
For more information, please contact:
Weber Shandwick Switzerland
Mrs. Alexia Fanni
Tel: +41 (0)22 879 85 07
[email protected]
Le European Tech Tour annonce le MedTech Summit,
Evénement paneuropéen dédié aux jeunes entreprises innovantes actives
dans le secteur médical
Genève, Le 9 Septembre 2008- Après avoir mis sur pied une série d’évènement
dédié à l’ensemble de l’industrie Européenne des semi-conducteurs et du web,
l’Association European Tech Tour est fière d’annoncer une nouvelle initiative mettant
à l’honneur le secteur médical dans son ensemble. Le European Tech Tour
MedTech Summit aura lieu les 19-20 Novembre 2008 à Montreux et Lausanne,
Suisse. Il s’agit du premier événement dédié à cette industrie dont l’objectif est
d’identifier, grâce à un Comite de Sélection composé des 20 meilleurs
professionnels du secteur, les 25 entreprises les plus novatrices ayant un potentiel
de croissance important à l’échelle internationale.
Cet événement est ouvert aux entreprises à différentes phases de leur
développement à savoir « Seed », « Start-up » « Expansion » et « Pre-IPO ». Ces
entreprises opèrent sur différents segments de marché regroupant les spécificités
suivantes : cardiovasculaire, neurologie, ophtalmologie, dentaire, orthopédie,
chirurgie, radiologie, mode d’administration de médicaments …
« Le Medtech est un secteur très porteur en terme d’investissements avec un
potentiel de croissance fort. L’objectif du MedTech Summit est double ;
premièrement de rassembler l’ensemble des acteurs de cette industrie afin de
débattre de sujets importants relatifs à la croissance de ce marché ainsi que de
présenter les entreprises les plus innovantes auprès de professionnels du capital
risque, de multinationales venues du monde entier. » déclare Brian Hashemi,
Président du MedTech Summit 2008.
Quelles sont les avantages pour les finalistes ? :
Les 25 finalistes auront 20 minutes pour présenter leur projet face à l’ensemble de la
communauté composée des plus grands investisseurs mondiaux actifs au sein de
cette industrie.
Cet événement pan-Européen leur permettra aussi de communiquer sur une échelle
mondiale avec à la clé la possibilité de trouver conseil et financement dans le but
d’accélérer la croissance internationale de leur entreprise.
A propos de ETT :
Le European Tech Tour, association à but non lucratif basée en Suisse, a été fondée
en 1998 pour répondre à l’intérêt croissant dont font preuve les experts du secteur
désireux de rencontrer des responsables de sociétés émergeantes dans différentes
régions d’Europe. ETT est une association indépendante rassemblant les
contributeurs clés de l’industrie high-tech. Pour assurer durablement la prospérité en
Europe, l’association est convaincue du fait que les atouts du vieux Continent
résident dans sa capacité à transformer les jeunes pousses novatrices d’aujourd’hui
en leaders d’envergure mondiale pour les technologies de demain.
Apres 10 ans d’existence le Européen Tech Tour à réalisé plus de 30 événements
en Europe, Israël, Russie et en Inde.
www.techtour.com
###
Pour plus d’informations merci de contacter :
Weber Shandwick Switzerland
Mme Alexia Fanni
Tel: +41 (0)22 879 85 07
[email protected]
The European Tech Tour Association Invests in Europe’s Medical Technology sector with the
European Tech Tour (ETT) MedTech Summit
Call for 2008 Applications – Deadline September 24, 2008
Geneva, September 2nd, 2008 – The European Tech Tour Association today announced the launch of
the ETT MedTech Summit 2008, a sector-specific event focused on bringing together Europe’s most
innovative Medical Technology companies with leading venture capitalists and senior industry
professionals. Selected companies will present to an international delegation of influential investors,
technology industry leaders, service providers and academics, offering participants the opportunity to
network, develop partnerships and potentially generate financing. MedTech start-up submissions for
the event, which will be held 19-20 November in Montreux and Lausanne, Switzerland, are now being
accepted and potential applicants should register online before September 24 at www.techtour.com.
The event, sponsored by Audemars Piguet, Endeavour Vision, Ecole Polythechnique Federal de
Lausanne, Swiss MedTech, Swiss Exchange, BioAlps, and Swiss Canton de Vaud is open to
companies in all stages of development including seed, start-up, expansion and pre-IPO that are
active in segments across the market including Cardiovascular, Neurology, Ophtalmology, Drug
Delivery, Imaging and Robotics, Biomaterials, Dental, Mininimal Invasive Surgery, and Othopedics.
Brian Hashemi, President of the MedTech Summit 2008, said: “Europe has always played a leading
role in the innovation of medical technologies and the goal of the 2008 European Tech Tour MedTech
Summit is to assemble the ecosystem of MedTech to debate important issues relating to this growing
sector and to introduce the most promising European MedTech companies to investment
professionals and corporate executives from around the world..“
Companies based or incubated in Europe, Israel and Russia are eligible to participate, and a company
profile, latest business plan and draft presentation must be submitted together with the online
registration form. Each registration will be reviewed by two members of the selection committee,
comprised of 20 senior-level business leaders from various backgrounds (see below).
Based on those reviews the 2008 MedTech Summit will feature:
•
Presentation of selected quality European MedTech investment opportunities by company
CEO’s to investment and industry professionals from across the globe
•
A MedTech expo featuring and exhibition of medical technologies from selected companies
•
Panel discussions and debate among MedTech experts from Europe and the U.S covering a
range of topics such as best practices in MedTech, Spin-outs from corporations and research
institutions, to growth valuation and exit opportunities in the MedTech sector.
The selection Committee for the ETT MedTech Summit :
Brian Hashemi, President of the ETT MedTech Summit
Beat Merz, Trigon Medical, VP of the Selection Committee
Mohit Kaushal, Polaris, Support of the Selection Committee
Ruti Alon, Pitango Venture, Israel
Johan Bennarsten, Capman, Sweden
Daniel Bertholet, Endeavour Vision, Switzerland
Joel Besse, Orion HCE, United Kingdom
Brian Chee, Polaris, USA
Aris Constantinides, NBGI, United Kingdom/ Germany
Benoit Dubuis, BioAlps Association
Arthur Franken, Gilde HP, the Netherlands
Graham Gardner, Highland, USA
Tim Haines, Abingworth, United Kingdom
Gerard Hascoet, AP Technologies, Switzerland
Brian Kerr, Scottish Equity Partner, United Kingdom
Jacques Mallet, Auriga, France
Claudio Nessi, Neomed, Norway/Switzerland
Thom Rasche, Earlybird
George Rehm, Aeris, Switzerland
Christian Schneider, FiveLakes, Germany
Rainer Strohmenger, Wellington Partners, Germany
Rafaele Tordjman, Sofinnova, France
Zeev Zahevi, Johnson&Johnson, Israel
Benefits for finalists
The 25 finalists will each have a twenty minute slot to present their business plans to senior partners,
vice presidents and CEOs from the global venture capital and technology industry and receive their
advice and feedback. In addition, they will benefit from:
•
Extensive networking with the delegates
•
Networking with up to 300 professionals from the local technology and venture capital community
•
Local and international media exposure
•
Potential opportunities to secure funding
•
No cost to selected finalists
Beat Merz, Vice President of Selection Committee said,
“The mission of the Selection Committee of the 2008 European Tech Tour MedTech Summit is to
identify the most promising European MedTech companies with global potential and to introduce them
to select investment professionals and corporate executives from around the world who seek to
partner with, and invest in European MedTech.”
About European Tech Tour
The European Tech Tour Association (ETT) is a non-profit organization founded by Sven Lingjaerde in
Switzerland in 1998 and has successfully organised 28 Tech Tours across Europe and Israel, Russia
and India, since its inception ten years ago. ETT is an independent organisation composed of key
contributors to the high-technology industry and responds to the growing interest to visit emerging
technology companies in various European regions,
The European Tech Tour Association recognises that the European continued prosperity lies in its
ability to transform today's innovative projects into tomorrow's global technology leaders. Focused on
the global expansion of emerging companies with a high index of growth, the association’s main
objective is to provide independent leading platforms designed to identify and support the emerging
companies with the necessary potential to impact in the technological global scenario.
For further information, please go to www.techtour.com
PRESENTING COMPANIES
Company
Company overview
BioControl develops and markets
advanced implantable devices for the
treatment of autonomic disorders. The
devices enable controlled electrical
stimulation of various nerves to achieve
therapeutic results.
Headquarters
Israel
www.biocontrol-medical.com
Biospace Med aims to become a global
leader in orthopedic imaging by
establishing a new gold standard that will
improve diagnostic, outcome and follow
up of osteoarticular pathologies and
subsequent treatments affecting all age
groups, from children to geriatric patients.
France
www.biospacemed.com
CeQur aims to improve the quality of life of
people with diabetes. With the use of
CeQur insulin infusion devices, patients will
have no more needles in their life, will
minimize the hassle of diabetes care, feel
better and reduce debilitating
complications.
Switzerland
1
Elana aims to improve the quality of life for
people with vascular diseases by
maintaining a leading edge in bypass
research and through the development of
unique solutions for surgery.
The Netherlands
www.elana.com
Endosense
aims
to
establish
their
technology as the first and leading forcesensing catheter for cardiac ablations.
Switzerland
www.endosense.com
EyeSense’s aspiration is to improve
diabetics’ quality of life by providing them
with a new self-diagnostic tool for blood
glucose measurement, which is by far more
convenient than the currently used
technique.
Germany
www.eyesense.com
Fertility Focus Ltd. (FFL) is a medical device
company focused on applying its expertise
in female healthcare to become a leading
player in the diagnosis and treatment of
infertility.
UK
www.fertility-focus.com
Forth Photonics is molecular imaging for
early detection and cancer prevention.
www.forth-photonics.com
UK
2
GluSense aims to become the gold
standard of continuous glucose monitoring
for the diabetes market, using its unique
GluSense implantable glucose sensor.
Israel
www.glusensemedical.com
IMI aims to restore visual perception to the
blind using an implantable retinal chip.
Switzerland
www.imidevices.com
Kuros aims to improve patient treatment
and create shareholder value by
developing innovative biologic and
biomaterial based products for localized
therapy in trauma, spine and wounds.
Switzerland
www.kuros.ch
Leman Cardiovascular aims to develop,
manufacture and distribute the novel
concept of a porcine composite biological
heart valve that combines the
performance of the stentless valves and
the easiness of handling and implantation
of the stented valves.
Switzerland
www.lemancardiovascular.com
LIFEBRIDGE Medizintechnik AG has set itself
the goal of providing mechanical
cardiovascular support to significantly
more patients than are receiving such
support today in the decisive moments of
their lives, thereby saving them from death,
immediately and at any location.
Germany
www.lifebridge.com
3
Develop and commercialise a new
catheter ablation technology for treatment
of Atrial Fibrilation.
Michelson Diagnostics Ltd (MDL) is a UKbased independent healthcare company
with a unique optical imaging technology,
providing live, sub-surface views of tissue at
unprecedented resolution.
Switzerland
UK
www.michelsondiagnostics.com
Novalung develops, manufactures and
markets devices that breathe outside the
patient to give the lung time to heal.
Germany
www.novalung.com
Management of fluid balance using an
implantable pump and catheters to move
fluids around inside the body.
Switzerland
www.novashunt.com
Occlutech is a rapidly expanding
European hi-tech medical device
company specializing in developing and
manufacturing cardiac occlusion devices
and other vascular implants for the
treatment of structural heart disease.
Sweden
www.occlutech.com
4
OptiNose aims to combine unique and
superior nasal drug delivery technology
with pharmaceutically active substances
to achieve significant therapeutic benefits,
improved safety profiles and increased
reproducibility.
Norway
www.optinose.com
Pantec Biosolutions is a private drug
delivery company specialising in laser
micro-poration technology to deliver large
molecular weight drugs into the epidermis
for systemic or topical uptake.
Liechtenstein
www.pantec-biosolutions.com
Skyline aims to become a global player in
the diagnostic field for oncology using
micro array technology.
The Netherlands
www.skyline-diagnostics.com
Slender Medical develops a leapfrog
ultrasound technology expanding the
frontiers of non-invasive body shaping.
Israel
www.slenderm.com
Symetis is a start-up developing innovative
medical devices for minimal invasive
replacement of diseased aortic valves.
Switzerland
www.symetis.com
5
Vexim is a European company dedicated
to bringing clinically and scientifically
proven solutions to minimally invasive
treatment of patients suffering from spinal
trauma disorders.
France
http://[email protected]
6